• as the potassium salt (KO2) to plasma resulted in significantly increased oxidative damage to proteins, indexed by protein carbonyl (PC) and protein-bound HNE levels. We then adapted this protocol for use in cell culture. Incubation of J774A.1 macrophage culture using this KO2-18crown6 protocol with 1 and 10 μM KO2 resulted in dramatically increased levels of TNF-α produced. These findings, together with our prior results, provide strong evidence that O2 − • and its resulting reactive species are critically involved in Doxinduced plasma protein oxidation and TNF-α release.
Introduction
More than half of the FDA approved anti-cancer drugs are known to cause reactive oxygen species (ROS) production [1] . Doxorubicin (Dox) is a quinone containing antineoplastic anthracycline used commonly in multi-drug chemotherapy regimens primarily to treat solid tumors [2] . Dox, a prototypical ROS-producing chemotherapeutic agent, in the presence of molecular oxygen, generates the reactive superoxide radical anion (O2 − • ) via redox cycling of the quinone moiety [3] [4] [5] [6] [7] . Our group has demonstrated that Doxinduced oxidative damage to plasma proteins in vivo induces the elevation of the inflammatory cytokine, tumor necrosis factoralpha (TNF-α), in the periphery [1, 2, 8] . TNF-α crosses the bloodbrain barrier (BBB) via receptor-mediated endocytosis resulting in central nervous system toxicities including further TNF-α elevation in brain, oxidative and nitrosative damage to key biomolecules, mitochondrial dysfunction, and neuronal death [8] [9] [10] [11] [12] [13] . O2
−
• is considered a key reactive radical generated within the cell leading to protein oxidation, lipid peroxidation, and hydrogen peroxide (H2O2) and hydroxyl radical ( • OH) production that can further damage biomolecules [14] [15] [16] [17] . The goal of this study was to determine if O2 − • produces oxidative protein damages in plasma and TNF-α elevation in macrophages similar to that observed following Dox administration in order to further elucidate the mechanisms Abbreviations: ROS, reactive oxygen species; Dox, doxorubicin; O2 − •, superoxide; TNF-α, tumor necrosis factor-alpha; BBB, blood-brain barrier; H2O2, hydrogen peroxide; •OH, hydroxyl radical; CICI, chemotherapy-induced cognitive impairment; ApoA-I, apolipoprotein A-I; WT, wild-type; KO2, potassium superoxide salt; PC, protein carbonyl; HNE, 4-hydroxy-2-trans-nonenal; BCA, bicinchoninic acid; DNPH, 2,4-dinitrophenylhydrazine; BSA, bovine serum albumin; BCIP, 5-bromo-4-chloro-3-indolyl-phosphate dipotassium; NBT, nitro blue tetrazolium chloride; ALP, alkaline phosphatase activity buffer; DMSO, dimethyl sulfoxide; 18crown6, crown ether, 18-crown-6; LPS, lipopolysaccharide; NF-κB, nuclear factor κ-light-chain enhancer of activated B cells; SOD, superoxide dismutase; NO•, nitric oxide.
by which Dox may cause chemotherapy-induced cognitive impairment (CICI), despite the inability of Dox or its major metabolite to cross the BBB. Previously, our laboratory demonstrated that Doxinduced oxidation of apolipoprotein A-I (ApoA-I) in J774.A1 macrophage culture led to increased TNF-α production [2] . To accomplish this goal, O2
• was added to plasma samples from wild-type (WT) mice in the form of potassium superoxide salt (KO2) in an appropriate solvent including an 18crown6 stabilizer [14, 18, 19] , and oxidative stress parameters, protein carbonyl (PC) and proteinbound 4-hydroxy-2-trans-nonenal (HNE), were measured. PC levels serve as a measure of protein oxidation, while protein-bound HNE is a lipid peroxidation product that damages proteins [20, 21] . The O2
• protocol we developed for our plasma experiments was then adapted for use in macrophage cell culture to determine if O2 − •
induces Dox-like TNF-α consequences.
Methods and materials

Chemicals
Chemicals, proteases, protease inhibitors, and antibodies used in this study were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise noted. Precision Plus Protein™ All Blue Standards, BCA reagents, and nitrocellulose membranes were purchased from Bio-RAD (Hercules, CA, USA).
Statistical analysis
All data are presented as mean ± SEM. Statistical analyses were performed using ANOVA (and Bonferroni's multiple comparison post-test) followed by a two-tailed Student's t-test to make individual comparisons between groups where appropriate, with p < 0.05 considered significant. Normality of data sets was tested using the D'Agostino & Pearson omnibus normality test where appropriate.
Animals
All procedures using animals were performed according to the protocols approved by the University of Kentucky Animal Care and Use Committee. Wild-type, male, SKH1 hairless, albino mice (2-3 months old) were purchased from the Jackson Laboratory. Mice were kept under standard conditions housed in the University of Kentucky Animal Facility, and all experimental procedures were approved by the Institutional Animal Care and Use Committee of the University of Kentucky. These animals were euthanized and blood and tissues collected for molecular or biochemical analysis. Whole blood collected by cardiac puncture was immediately collected in EDTA tubes and plasma immediately separated by centrifugation.
Sample preparation
Protein estimation was performed using the bicinchoninic acid (BCA, Pierce) assay. Homogenized plasma samples were diluted according to initial protein estimation results using 20 μg sample in isolation buffer [0.32 M sucrose, 2 mM EDTA, 2 mM EGTA, and 20 mM HEPES pH 7.4 with protease inhibitors, 0.2 mM PMSF, 20 μg/mL trypsin inhibitor, 4 μg/mL leupeptin, 4 μg/mL pepstatin A, and 5 μg/mL aprotinin].
Slot blot assay
The slot-blot method was used to determine levels of protein carbonyl and proteinbound HNE in plasma as previously described [2, 22] . For protein carbonyl determination, samples were derivatized with 2,4-dinitrophenylhydrazine (DNPH). For protein-bound HNE, samples were solubilized in Laemmli buffer. Protein (250 ng) from each sample was loaded onto a nitrocellulose membrane in respective wells in a slot-blot apparatus (Bio-Rad) under vacuum. Nitrocellulose membranes were blocked in 3% bovine serum albumin (BSA) in PBS with 0.2% (v/v) Tween-20 for 1.5 h and then incubated in primary antibody (anti-dinitrophenylhydrazine primary or anti-protein-bound HNE, respectively, each produced in rabbit, Sigma-Aldrich) for 2 h, washed three times in PBS with 0.2% (v/v) Tween-20 and then incubated for 1 h with secondary antibody (goat anti-rabbit secondary linked to alkaline phosphatase). Nitrocellulose membranes were developed with 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) dipotassium and nitro blue tetrazolium (NBT) chloride in alkaline phosphatase activity (ALP) buffer, dried, and scanned for analysis. Image analysis was performed using Scion Image (Scion Corporation, Frederick, MD).
Solvent selection and potassium superoxide solution preparation
KO2 is a yellow solid that reacts readily with water and decomposes if exposed to water vapor or carbon dioxide in air. To avoid this, a saturated solution of KO2 was prepared fresh, according to the method previously described [14, 18, 19] , in a solvent of anhydrous dimethyl sulfoxide (DMSO) containing 200 mM crown ether (18crown6) to aid in solubility. To the prepared solvent, excess KO2 was added and the KO2 concentration estimated by UV-vis absorbance and using Beer's law [18, 23] . A saturated solution of KO2 was approximately 250 μM under the stated conditions. Serial dilutions of this saturated solution were performed using the DMSO+18crown6 solvent to obtain the desired O2 − • concentrations.
Plasma oxidation with potassium superoxide
KO2 in a solvent of DMSO containing 18crown6 was added to plasma from WT mice (2-3 months old WT, male, SKH1 hairless, albino mice purchased from the Jackson Laboratory) and incubated at 37°C for 0, 15, 30, and 90 min. Concentrations of 0, 0.1, 1.0, or 10 μM KO2 made using serial dilution were added to plasma to broadly encompass Dox concentrations used in previous studies. The solvent, DMSO containing 18crown6, was added to all control incubations.
Macrophage stimulation with potassium superoxide
Cell culture experiments were carried out using mouse BALB/c monocyte macrophage cell line (J774A.1) collected from murine blood. The mouse macrophage cell line J774A.1 (American Type Culture Collection) was cultured in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) fetal bovine serum, streptomycin (100 μg/mL), and penicillin (100 U/mL). All cultures were incubated at 37°C in a humidified atmosphere with 5% CO2. J774A.1 macrophage cells were plated at a density of 5 × 10 5 cells/well in 48-well plates. J774.A1 macrophages were seeded onto a 48-well plate at 5 × 10 5 cells/well and allowed to grow overnight under standard culture conditions. KO2 was prepared as described above. Preincubation of solvent, lipopolysaccharide (LPS; 1 μg/mL), KO2 (0.1 μM; 1 μM; 10 μM) for 1 h was performed before their addition to J774.A1 macrophages. Lipopolysaccharide (LPS; 1 μg/mL) or KO2 (0.1 μM; 1 μM; 10 μM) was added and the cells were incubated for 24 h and compared with cells incubated in media only and cells incubated in media containing DMSO + 18crown6 vehicle. The supernatant was collected and levels of TNF-α (pg/mL) were determined with a specific ELISA kit for mouse TNF-α (R&D Systems).
Results
Protocol development
A variety of solvents and combinations were explored to make a stable solution of KO2. KO2 releases O2 − • upon addition to an aqueous environment [14] . O2 − • then reacts rapidly with water present in any solvent combination forming H2O2. In this study, the reaction of KO2 with water was more rapid and vigorous than expected. In fact, KO2 reacted with water vapor in the air during any attempt at weighing KO2, contrary to some methods describing standard weighing preparation or preparation in a water-based solution [24, 25] . Transition metals are known to influence the reactivity of dioxygen radicals including those present in O2 − • [26] . Chelex removal of metal ions did not prevent this problem [27] , and prior addition of catalase to the solvent only accelerated the reaction of KO2 with water presumably by reacting away the formed H2O2 and shifting the reaction equilibrium toward product [28] [29] [30] . This prompted the pursuit of a suitable anhydrous solvent for KO2. KO2 is slightly soluble in anhydrous DMSO [31] . A crown ether, 18crown6, was used to enhance solubility and stability [19] .
Plasma oxidation from potassium superoxide
Plasma samples were treated with 0, 0.1, 1.0, or 10 μM KO2 for 0, 15, 30, and 90 min and analyzed via slot blot to determine relative levels of PC and protein-bound HNE as measures of protein oxidation and lipid peroxidation, respectively [20, 21] . PC damage to protein in plasma following incubation with KO2 was rapid. Using 10 μM KO2, PC levels for each successive time point were significantly elevated over the previous one indicated by Bonferroni's Multiple Comparison Test. After 15 min incubation at 37°C, significant increases in PC were observed at 0.1, 1, and 10 μM KO2 (Fig. 1a , ***p < 0.005, ***p < 0.005, and **p < 0.01, respectively). Significant increases in PC in plasma were also observed at each concentration, 0.1, 1, and 10 μM, of KO2 measured after 15 min incubation at 37°C (Fig. 1b , ***p < 0.005, ***p < 0.005, and **p < 0.01, respectively). Similar experiments were performed to assess KO2-induced protein-bound HNE in plasma. Protein-bound HNE was significantly elevated after 30 and 90 min incubations with 10 μM KO2 at 37°C (*p < 0.05, #p < 0.001, respectively) (Fig. 1c) . Protein-bound HNE levels were not significantly elevated at the KO2 concentrations tested for the 15 min incubation at 37°C. Significant increases in protein-bound HNE levels were seen after 30 min incubation at 37°C with the 10 μM KO2 concentration (*p < 0.05) and after 90 min incubation at 37°C with the 1 μM and 10 μM KO2 concentrations (*p < 0.05, #p < 0.001, respectively) (Fig. 1d) . The higher concentrations of KO2 and longer incubation times were required to reach significant increases in protein-bound HNE following KO2 addition ( Fig. 1c and  d) . Decisions for moving forward were based on these preliminary KO2 dose-response results with varied incubation times.
Superoxide induces TNF-α elevation in macrophage culture similar to that seen following doxorubicin administration
Previously, we reported TNF-α elevation in plasma or macrophage culture following Dox treatment and O2 − • produced through redox cycling of Dox as the likely cause [2, 10] . Our group also demonstrated in a cross-over human clinical study that TNF-α and soluble TNF-α receptor levels are elevated in human plasma following i.v. Dox administration [32] . Macrophages are a principal source of TNF-α production in vivo [33] [34] [35] , and microglial activation in brain following Dox-induced TNF-α elevation leads to the previously mentioned central nervous system toxicities [24, 33] . Here, we test our hypothesis that O2 − • , administered as KO2, will lead to TNF-α elevation in macrophage culture similar to that observed following Dox administration [2] . Significantly increased TNF-α elevation in J774.A1 macrophage culture after incubation with KO2 for 24 h was observed. TNF-α was increased in these cell lines following incubation with 1 and 10 μM KO2 (***p < 0.0001) (Fig. 2) . Incubation of these macrophages with the 10 μM KO2 concentration resulted in TNF-α greater than treatment of the cells with lipopolysaccharide (LPS; 1 μg/mL), a known initiator of TNF-α transcription via nuclear factor κ-light-chain enhancer of activated B cells (NF-κB) (Fig. 2)  [36-41] . , and 90 min incubations with 10 μM KO2 at 37°C. All incubation times tested at 10 μM KO2 and 37°C, 15, 30, and 90 min, resulted in significantly increased PC compared to solvent alone (**p < 0.01, ##p < 0.0001, ##p < 0.0001, respectively). PC for each successive time point at 10 μM KO2 was significantly elevated over the previous one indicated by Bonferroni's Multiple Comparison Test. (b) Significant increases in PC were observed at 0.1, 1, and 10 μM KO2 after 15 min incubation at 37°C (***p < 0.005, ***p < 0.005, and **p < 0.01, respectively). (c) Protein-bound HNE was significantly elevated after 30 and 90 min incubations with 10 μM KO2 at 37°C (*p < 0.05, #p < 0.001, respectively). (d) Proteinbound HNE levels were not significantly elevated at the KO2 concentrations tested for the 15 min incubation at 37°C. Significant increases in protein-bound HNE levels were seen after 30 min incubation at 37°C with the 10 μM KO2 concentration (*p < 0.05) and after 90 min incubation at 37°C with the 1 μM and 10 μM KO2 concentrations (*p < 0.05, #p < 0.001, respectively).
Discussion
Prior studies by our laboratory implicated O2 − • , produced in vivo via the redox cycling of the chemotherapeutic agent Dox, in increased oxidative damage to plasma proteins, elevation of TNF-α in the periphery, followed by transfer of TNF-α to brain and further TNF-α elevation in the parenchyma. Subsequent CNS toxicity including mitochondrial dysfunction and neuronal death was observed, and we suggest such processes are involved in CICI [1, 2, [8] [9] [10] [11] [12] [13] 42] . The quinone moiety within the molecular structure of Dox cycles between the quinone and semi-quinone, producing superoxide free radical from molecular oxygen as it cycles back to the quinone [2] [3] [4] [5] 42] . The current study was undertaken to test the plausibility of our hypothesis that O2 − • from Dox is responsible for oxidative protein damage, TNF-α elevation, and cognitive consequences observed following chemotherapy with ROS-producing anti-cancer drugs, like Dox, that do not cross the BBB but result in these unwanted clinical signs and symptoms.
In the current study, superoxide caused oxidative damage to plasma proteins in vitro rapidly and at small concentrations of KO2, similar to damage caused by Dox. All incubation times tested, 15, 30, and 90 min, resulted in significantly increased plasma protein oxidative damage as indicated by PC elevation with PC at each successive time point significantly increased over the previous one (Fig. 1a) [20] . Significant PC elevation was observed in plasma even at the lowest concentrations of KO2 tested (Fig. 1b) . Evidence of lipid damage was also found in KO2-treated plasma in the form of proteinbound HNE, a product of lipid peroxidation [21] (Fig. 1c) . Significant increases in protein-bound HNE were observed after 30 min incubation at 10 μM KO2 (Fig. 1c and d) and at 1 and 10 μM KO2 (Fig. 1d ).
Higher concentrations of KO 2 and longer incubation times tested were required to reach significant increases in protein-bound HNE following KO2 addition (Fig. 1c) This study directly addresses a critical aspect of our proposed mechanism of CICI, the question of whether superoxide, produced via redox cycling of Dox, is an oxidant capable of inducing oxidative damage to plasma protein and TNF-α elevation in macrophages, the proposed cytokine culprit of CICI [2, 32] . These results are consistent with our previous results demonstrating increased protein oxidation and lipid peroxidation markers in plasma and subsequent TNF-α elevation following Dox administration in vivo and in macrophage culture. These results demonstrate that O2 − • , when added to plasma in the form of KO2 salt, stabilized by the molecular cage of a crown ether, 18crown6, and incubated at physiologic 37°C, results to protein oxidation in plasma and TNF-α elevation in macrophage culture similar to that observed following Dox administration in vivo. Together, these results are compelling evidence supporting the notion that O2 − • production as a result of Dox administration is the likely initiating event in the neurotoxicity associated with Dox and provides useful insights into our hypothesized mechanism of CICI caused by cancer chemotherapy with ROSproducing chemotherapeutic agents like Dox.
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